172 related articles for article (PubMed ID: 32662712)
1. Caspofungin: a review of its characteristics, activity, and use in intensive care units.
Hashemian SM; Farhadi T; Velayati AA
Expert Rev Anti Infect Ther; 2020 Dec; 18(12):1213-1220. PubMed ID: 32662712
[TBL] [Abstract][Full Text] [Related]
2. Systematic review on the first line treatment of amphotericin B in critically ill adults with candidemia or invasive candidiasis.
Keane S; Geoghegan P; Povoa P; Nseir S; Rodriguez A; Martin-Loeches I
Expert Rev Anti Infect Ther; 2018 Nov; 16(11):839-847. PubMed ID: 30257597
[TBL] [Abstract][Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and Treatment of Candidemia in the Intensive Care Unit.
Bassetti M; Giacobbe DR; Vena A; Wolff M
Semin Respir Crit Care Med; 2019 Aug; 40(4):524-539. PubMed ID: 31585478
[TBL] [Abstract][Full Text] [Related]
5. [Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins].
Almirante B; Garnacho-Montero J; Maseda E; Candel FJ; Grau S; Guinea J; Moreno I; Muñoz P; Ruiz-Santana S
Rev Esp Quimioter; 2017 Oct; 30(5):355-367. PubMed ID: 28945064
[TBL] [Abstract][Full Text] [Related]
6. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
7. EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodríguez A;
Rev Esp Quimioter; 2014 Sep; 27(3):196-212. PubMed ID: 25229375
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysis.
Bienvenu AL; Pradat P; Guerin C; Aubrun F; Fellahi JL; Friggeri A; Guichon C; Hernu R; Menotti J; Monard C; Paulus S; Rimmele T; Piriou V; Chidiac C; Argaud L; Leboucher G
Int J Infect Dis; 2020 Apr; 93():15-21. PubMed ID: 31982622
[TBL] [Abstract][Full Text] [Related]
9. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting Fungal Echinocandin Resistance by Small-Molecule Disruption of Geranylgeranyltransferase Type I Activity.
Sun Q; Xiong K; Yuan Y; Yu J; Yang L; Shen C; Su C; Lu Y
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791942
[TBL] [Abstract][Full Text] [Related]
11. Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study).
Jarque I; Tormo M; Bello JL; Rovira M; Batlle M; Julià A; Tabares S; Rivas C; Fernández-Sevilla A; García-Boyero R; Debén G; González-Campos J; Capote FJ; Sanz MA;
Med Mycol; 2013 Feb; 51(2):150-4. PubMed ID: 22712457
[TBL] [Abstract][Full Text] [Related]
12. Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.
Kullberg BJ; Viscoli C; Pappas PG; Vazquez J; Ostrosky-Zeichner L; Rotstein C; Sobel JD; Herbrecht R; Rahav G; Jaruratanasirikul S; Chetchotisakd P; Van Wijngaerden E; De Waele J; Lademacher C; Engelhardt M; Kovanda L; Croos-Dabrera R; Fredericks C; Thompson GR
Clin Infect Dis; 2019 May; 68(12):1981-1989. PubMed ID: 30289478
[TBL] [Abstract][Full Text] [Related]
13. Mind the gaps: challenges in the clinical management of invasive candidiasis in critically ill patients.
Peçanha-Pietrobom PM; Colombo AL
Curr Opin Infect Dis; 2020 Dec; 33(6):441-448. PubMed ID: 33044240
[TBL] [Abstract][Full Text] [Related]
14. Low Caspofungin Exposure in Patients in Intensive Care Units.
van der Elst KC; Veringa A; Zijlstra JG; Beishuizen A; Klont R; Brummelhuis-Visser P; Uges DR; Touw DJ; Kosterink JG; van der Werf TS; Alffenaar JC
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855112
[TBL] [Abstract][Full Text] [Related]
15. Candidemia in Adult Patients in the ICU: A Reappraisal of Susceptibility Testing and Antifungal Therapy.
Chastain DB; White BP; Tu PJ; Chan S; Jackson BT; Kubbs KA; Bandali A; McDougal S; Henao-Martínez AF; Cluck DB
Ann Pharmacother; 2024 Mar; 58(3):305-321. PubMed ID: 37272474
[TBL] [Abstract][Full Text] [Related]
16. Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration.
Pérez-Pitarch A; Ferriols-Lisart R; Aguilar G; Ezquer-Garín C; Belda FJ; Guglieri-López B
Int J Antimicrob Agents; 2018 Jan; 51(1):115-121. PubMed ID: 28666752
[TBL] [Abstract][Full Text] [Related]
17. Intensive care medicine research agenda on invasive fungal infection in critically ill patients.
Bassetti M; Garnacho-Montero J; Calandra T; Kullberg B; Dimopoulos G; Azoulay E; Chakrabarti A; Kett D; Leon C; Ostrosky-Zeichner L; Sanguinetti M; Timsit JF; Richardson MD; Shorr A; Cornely OA
Intensive Care Med; 2017 Sep; 43(9):1225-1238. PubMed ID: 28255613
[TBL] [Abstract][Full Text] [Related]
18. Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata.
Wiederhold NP; Najvar LK; Jaramillo R; Olivo M; Pizzini J; Catano G; Patterson TF
J Antimicrob Chemother; 2018 Feb; 73(2):448-451. PubMed ID: 29177447
[TBL] [Abstract][Full Text] [Related]
19. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.
van der Geest PJ; Hunfeld NG; Ladage SE; Groeneveld AB
BMC Infect Dis; 2016 Sep; 16():490. PubMed ID: 27634140
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of caspofungin in critically ill patients. ProCAS Study.
León-Gil C; Ubeda-Iglesias A; Loza-Vázquez A; de la Torre MV; Raurich-Puigdevall JM; Alvarez-Sánchez B; Ortiz-Leyva C; Domínguez-Roldán JM; Socías-Crespi L; Garnacho-Montero J;
Rev Esp Quimioter; 2012 Dec; 25(4):274-82. PubMed ID: 23303260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
